Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies

In addition to statin therapy, Ezetimibe, a non-statin lipid-modifying agent, is increasingly used to reduce low-density lipoprotein cholesterol and atherosclerotic cardiovascular disease risk. Literature suggests the clinical effectiveness of Ezetimibe plus statin (EPS) therapy; however, primary ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasidharan, Akhil, Bagepally, Bhavani Shankara, Kumar, S. Sajith, Jagadeesh, Kayala Venkata, Natarajan, Meenakumari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202874/
https://www.ncbi.nlm.nih.gov/pubmed/35709152
http://dx.doi.org/10.1371/journal.pone.0264563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202874/
https://www.ncbi.nlm.nih.gov/pubmed/35709152
http://dx.doi.org/10.1371/journal.pone.0264563

Ejemplares similares